Company attributes
Industry
Location
Accelerator
Country
Venture Capital Firm attributes
Invested in
Other attributes
Company Operating Status
Active
Vanderbilt University Office of Investments is an accelerator firm in Nashville that provides funds for the Vanderbilt University and Medical Center. Founded in Nashville, Tennessee, this company invests in early stage ventures. Vanderbilt University Office of Investments has invested in NephroGenex on Jul 6, 2007. This investment in the Series A round of NephroGenex was valued at $3.3M. NephroGenex is a drug-development company in Princeton focusing on kidney disease and progression of diabetic kidney disease. Vanderbilt University Office of Investments later exited the company.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Associated Investment Funds
Accelerator Batches
Patents
Funding Rounds Participated In
Further Resources
No Further Resources data yet.
